RightBio Metrics

Executive Summary

RightBio Metrics is a San Diego-based medical device company dedicated to improving patient safety during nasogastric (NG) and orogastric (OG) tube placements. Traditional verification methods rely on X-rays, which expose patients to radiation and delay confirmation. The company's flagship RightSpotpH® Indicator offers a fast, accurate, and radiation-free alternative by measuring gastric pH to confirm correct placement, reducing the risk of serious complications such as tube misplacement into the lungs. The device addresses a critical need in hospitals and emergency settings, where NG/OG tubes are frequently used. RightBio's solution provides real-time verification, potentially reducing healthcare costs and improving patient outcomes. With a focus on innovation and a strong value proposition in patient safety, the company is positioned for growth, pending regulatory expansions, clinical evidence generation, and strategic partnerships.

Upcoming Catalysts (preview)

• Q3 2026Publication of Clinical Study Results for RightSpotpH® Indicator70% success
• Q4 2026Strategic Partnership with a Major Hospital Network60% success
• Q1 2027Reimbursement Coding Approval from CMS50% success